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The  HLA-D region encodes a  series of polymorphic differentiation antigens 
that appear to be involved in the control of cellular interactions in the generation 
of an  immune  response  (1).  Two types of HLA-D region products  have been 
serologically identified,  the DR antigens,  which are homologous to the murine 
I-E molecules, and the DQ (formerly DS or DC) antigens, which are homologous 
to the murine I-A molecules (2, 3). These antigens consist of two noncovalently 
associated  subunits  (alpha,  34  kD;  beta,  27  kD)  and  both  the  DR  and  DQ 
molecules carry antigenic specificities defined by alloantisera  (4,  5).  Within  the 
DQ series, two alpha and two beta chain genes have been identified in the haploid 
genome,  and  hybridization  data  suggest additional  genes (6,  7).  Evidence also 
exists for the expression of two distinct  I-A-like molecules (8-10).  The studies 
reported here provide evidence not only for the expression of two distinct DQ- 
like molecules but show that each of these carry distinct alloantigenic specificities 
that can be defined by monoclonai antibodies. 
Materials and Methods 
Cells and Antibodies.  Lymphoblastoid cell lines (LCL) ~  were produced by Epstein-Barr 
virus (EBV) transformation of peripheral blood lymphocytes.  The families and HLA-Dw 
homozygous cells were characterized at the Seventh and Eighth  International Histocom- 
patibility  Workshops or with  reagents  of the Workshop.  The homozygous cells were 
obtained locally or through exchange. Monoclonal antibodies (MAb) Genox 3.53 (IgG1) 
(11),  L243 (IgG2)  (12), and 2.06 (IgG2)  (13) were obtained from the American Type 
Culture Collection,  Rockville, MD and MAb S1 and R1 (IgM) (14) and 16.23 (IgG3) (15) 
were produced in this laboratory. MAb Leu-10 was obtained from Becton, Dickinson & 
Co., Mountain View, CA. Typing was performed on 3-6-d-old phytohemagglutinin blasts 
using  a  single-cell, peroxidase-linked,  enzyme-linked  immunosorbent assay (ELISA) as 
previously described (16). 
Immunoprecipitation.  Cells were radiolabeled using the lactoperoxidase-glucose  oxidase 
procedure  (17),  lysed  in  1%  taurocholate  (Sigma  Chemical  Co.,  St.  Louis,  MO)  in 
phosphate-buffered saline,  pH  8,  containing  2  mM  benzamidine  hydrochloride (EGA 
Chemie,  Steinhiem/Albruch,  FRG)  and  2  mM  phenylmethylsuifonyl  fluoride  (.Fluka 
A. G., Buchs, Switzerland).  Immunoprecipitation was performed by incubating 10' cpm 
for 6-12  h at 4°C with  20 ttl protein A-Sepharose (Sigma Chemical  Co.) which  had 
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previously been incubated with rabbit anti-mouse Ig (Sigma Chemical Co.) and MAb as 
culture supernatant. Bound material was eluted by boiling in sodium dodecyl sulfate (SDS) 
sample buffer and was analyzed by electrophoresis  under reducing conditions on  10% 
SDS-polyacrylamide gel electrophoresis (PAGE) (18). Fixed, dried gels were exposed with 
an intensifying screen at -70°C  to Kodak XAR-5 film. 
Results 
Monoclonal Antibodies SI, Rl, and Genox 3.53 Are Directed Against an Alloanti- 
genic Specificity Similar to DQwl.  MAb S1 and R1 detect polymorphic B lympho- 
cyte antigens that segregate with HLA and display biochemical characteristics of 
Ia-like antigens (14). Analysis of binding with a panel of cells obtained from 68 
unrelated individuals revealed a strong association between the binding of these 
MAb and the presence of the DR antigens 1, 2, or w6 (Table I), a characteristic 
of the DQwl  (formerly DC1) alloantigen (19). MAb Genox 3.53, which has been 
shown  to  detect  the  DQwl  alloantigen  (20),  displayed  a  similar  DR  antigen 
association in this panel.  Genox  3.53  precipitates  DQ (I-A like) molecules that 
are distinguishable in some cells from the DR (I-E like) molecules in SDS-PAGE 
(4, 21). As seen in Fig.  1, Ia molecules precipitated from the cell line Schl (Dw6 
homozygous) by Genox 3.53  (Fig.  1,  lane 6) migrate faster than the HLA-DR- 
associated molecules precipitated by  16.23  (lane  7). Both MAb S1  (Fig.  1, lane 
TABLE  I 
Association of Determinants  Detected by Monoclonal Antibodies with DR 
AUoantigens 1, 2, and w6 
MAb  +  +*  +  -  -  +  -  -  n $  X  2 
SI  33  10  3  22  68  25.87 
R1  36  12  0  20  68  28.94 
Ge  36  5  0  27  68  46.92 
* Binding of MAb, presence of DR 1, 2, or w6. 
Number of individuals tested. 
FIGURE  1.  la-like antigens precipitated from a  DRw6 homozygous LCL by MAbs. Immu- 
noprecipitates were prepared from surface-iodinated Sch LCL as described in Materials and 
Methods and separated on 10% SDS-PAGE under reducing conditions. The numbers at the 
left indicate the position of molecular weight markers (46 kD, ovalbumin; 30 kD, carbonic 
anhydrase). Antigens precipitated by MAb RI, $1, and Genox 3.53 are in lanes 1, 5, and 6, 
respectively. DR-like antigens precipitated by MAb $2 (Drw6-associated), $3 (MT2-1ike),  R3 
(MT2-1ike), and 16.23 (DR3-associated) are in lanes 2, 3, 4, and 7, respectively. Characteriza- 
tion of MAb $2, R3, and $3 has been presented elsewhere (14). 1352  cis-ENCODED  DQ  ALLOSPECIFICITIES 
FIGURE 2.  Serial immunoprecipitation  of Ia antigens from iodinated ChfJag (HLA-DR 6,6). 
Immunoprecipitates were prepared as described in the text and separated on 10% SDS-PAGE 
under reducing conditions. (a) Sequential immunoprecipitation  using Leu-10 (anti-HLA-DQ). 
Immunoprecipitates obtained after one round (lanes I, 5, 9) and six rounds (lanes 2, 6, 10) of 
incubation with Leu-10. These lysates were then precipitated with MAb RI (lane 3), Genox 
3.53 (lane 7), and 16.23 (lane 11). Control lysates were exposed to six rounds of precipitation 
with a mouse myeloma and then immunoprecipitated with R1 (lane 4), Ge (lane 8), and 16.23 
(lane 12). (b) Sequential immunoprecipitation  using L243 (anti-HLA-DR). lmmunoprecipitates 
obtained after one round (lanes 1, 5, 8), and six rounds (lanes 2, 6, 9) of incubation with MAb 
L243. Lysates were then precipitated with MAb R1  (lane 3), Genox 3.53 (lane 7), or 16.23 
(lane 10). Control lysates were exposed to six rounds of precipitation with a mouse myeloma 
and then immunoprecipitated with R1 (lane 4), or 16.23 (lane 11). JOHNSON  AND  WANK  1353 
5) and R1  (lane 1) precipitated molecules from this cell line that migrated with 
the characteristics of the DQ (Genox) rather than  the DR  (16.23)  molecules. 
That the antigens precipitated by R1, S1, and Genox all belong to a population 
of DQ molecules was directly shown by sequential immunoprecipitation using 
DR- and  DQ-specific antibodies  (Fig.  2).  MAb  Leu-10  detects a  determinant 
common to  the  DQ molecules of most haplotypes (21).  MAb  L243  has been 
shown by analysis on HLA-D region mutants of LCL to be directed against the 
products of the DR  locus (22).  Iodinated LCL (HLA-DR 2,2;  DR  2,3; or DR 
6,6) were exposed to several rounds of precipitation with L243,  Leu-10, or an 
irrelevant antibody and  then  precipitated  with  MAb  S1,  R1  Genox  3.53,  or 
16.23. As can be seen in Fig. 2 a (ChfJag; HLA-DR 6,6), MAb Leu-10 removed 
molecules binding to RI  (lanes 1-4) and Genox (lanes 5-8) but not to  16.23 
(lanes 9-12).  MAb L243  (Fig.  2  b) removed 16.23-binding molecules (lanes 8- 
11) but not those binding R1 (lanes 1-4) or Genox (lanes 5-7). Identical results 
were obtained for S 1- as well as R 1-binding molecules in all three cells examined. 
MAb S1, R1, and Genox 3.53 Detect Different Epitopes and Define Two Distinct 
Alloantigenic  Specificities.  Although  all  three  MAb  appeared  to  be  directed 
against a  DQwl-like alloantigenic specificity, it can be seen from Table I  that 
complete concordance in the binding of the three antibodies was not observed. 
This suggests that they may detect distinct epitopes denoted here as S 1, R 1, and 
Ge.  Fifty unrelated individuals whose B lymphocytes expressed at least one of 
these three epitopes were investigated. While the majority expressed all three 
determinants, 15 variant individuals were found. Seven expressed only R1  and 
Ge and eight expressed only S1  and R1.  No cells in the panel were found that 
expressed only a single determinant or that expressed S1 and Ge in the absence 
of R1.  Through segregation analysis in  13  families, haplotypes of three types 
were identified: S 1  +/R 1  +/Ge  +, S 1  +/R 1  +/Ge-, and S 1  -/R 1  +/Ge  +. Thus, the three 
different epitope combinations observed in the unrelated panel were heritable 
and did not merely reflect variations in the B lymphocyte antigen expression. 
The number of variant cells (i.e., those individuals expressing only two of the 
three DQw 1 determinants) was too few to indicate an association of the variant 
phenotype with a given DR antigen. However, when a panel of HLA-D homo- 
zygous cells was investigated, an association could be detected. In a study of 41 
homozygous cells covering the specificities Dw  1-10,  the SI+/RI+/Ge+ pheno- 
type was found in all cells expressing the DR antigens  1,  2,  or 6  (Fig.  3).  The 
S1-/RI+/Ge + phenotype  was  not  found  in  this  panel  but  the  SI+/RI+/Ge  - 
phenotype was detected in  all  cells tested that  were homozygous for the DR 
specificities 4  and  w8.  In  the  unrelated panel  of Table  I,  the  S I÷/RI+/Ge  - 
phenotype was found in approximately half of the individuals bearing DR4 or 
DRw8 antigens. 
Two Distinct DQw  l-like Alloantigens Are Encoded on One Haplotype.  The obser- 
vations above  provide  evidence that  the  MAbs described define two  distinct 
DQwl-like alioantigens, one of which is defined by the epitopes S1 and R1, and 
one of which is  defined by the epitopes  S1,  R1,  and  Ge.  To  investigate  the 
relationship between these alioantigens, LCL from four heterozygous individuals 
where the three epitopes could be assigned to the same chromosome through 
segregation analysis  were analyzed  using  sequential  immunoprecipitation.  In- 1354  cis-ENCODED  DQ  ALLOSPECIFICITIES 
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FIGURE 3.  Distribution of epitopes detected by monoclonal antibodies Ge, S1, and RI  in 
HLA-D/DR homozygous cells. The DR and Dw antigens are listed on the left and the number 
of cells of each specificity that were tested (n) on the right. A black bar indicates presence of 
the epitope and a  blank space indicates its absence. Presence of the epitope was determined 
using a single-cell ELISA. 
cluded were haplotypes bearing DR1  (one cell), DR2 (two cells), and DRw6 (one 
cell). Lysates from surface-iodinated LCL were subjected to five to seven rounds 
of precipitation with the first MAb and then exposed to the second MAb. Finally, 
the lysates were incubated with MAb  16.23 or 2.06, which precipitate DR-like 
antigens. Fig. 4 presents the data from one of the two DR2 cells. Identical results 
were  obtained  from all  four ceils  examined.  The  molecules precipitated  by 
Genox 3.53 and those precipitated by either S 1 or R 1 appear to be independent. 
Thus, complete removal of Rl-reactive (Fig. 4 a, lanes 1-3) or Sl-reactive (Fig. 
4  b, lanes 1-3) molecules did not deplete Genox 3.53-reactive molecules (lane 
4, Fig. 4, a and b). Complete removal of Genox 3.53-reactive molecules (lanes 
6-8, Fig. 4, a and b) did not remove R 1-reactive molecules (Fig. 4 a, lane 9) nor 
Sl-reactive molecules (Fig. 4  b, lane 9).  The R1- and Sl-bearing molecules on 
the other hand, appear to be related, since removal of the Sl-bearing molecules 
depleted also the R 1-reactive molecules (Fig. 4 c, lanes 1-5) and vice versa (Fig. 
4  c, lanes 6-10). (In Fig. 4  c, the films were deliberately overexposed to allow 
detection of remaining RI+S1 - and R1-S1 + molecules.) Results obtained on an 
SI+/RI+/Ge  - cell (Va Schw, HLA-DR 4,5) indicate that S1 and R1 epitopes are 
located on the same molecules in these cells as well (data not shown). 
Discussion 
The Ia-like antigen epitopes defined by MAb S1, R1, and Genox 3.53 show a 
strong association with the DR specificities l, 2, and w6, suggesting that they all 
detect a  DQwl-like  specificity (19).  The  molecules precipitated  by  all  three 
antibodies are removed by prior exposure to an anti-DQ MAb (Leu-10) but not 
an anti-DR MAb (L243), indicating that all are DQ rather than DR molecules. 
Two observations, however, indicate that these antibodies actually define two 
distinct aUoantigenic specificities. Haplotypes encoding R 1 and S 1 molecules but 
lacking Ge  molecules were observed, and analysis of a  panel of homozygous 
typing cells showed an association of this pattern with DR4/Dw4 and DR8/Dw8 
cells. Reciprocal sequential immunoprecipitation using cells in which the R1, S1, 
and Ge epitopes were encoded by the same chromosome showed that two distinct Fmoa~  4.  Serial immunoprecipitation of DC-like antigens from iodinated LCL of Mo Lea 
(HLA-DR 2,3). lmmunoprecipitates were prepared as described in the text and separated on 
10%  SDS-PAGE under reducing conditions. R1,  S1,  and Ge  indicate immunoprecipitates 
preparedwith the respective monocional antibodies. C is an immunoprecipitate prepared at 
the end of each  experiment using the  control monoclonal antibody 16.23.  (a)  Sequential 
immunoprecipitation with MAb R1  and Genox 3.53. Immunoprecipitate obtained after one 
round (lane 1),  two  rounds (lane 2),  and six rounds (lane 3) of incubation with MAb R1. 
Precleared lysate was then exposed to Genox 3.53 (lane 4) and 16.23 (lane 5). In lanes 6-10, 
the lysate was exposed to six rounds of precipitation with Genox 3.53 (lanes 6-8) and then 
precipitated with RI  (lane 9) and  16.23 (lane 10). (b) Sequential immunoprecipitation with 
MAb SI  and Genox 3.53.  The  lysate was  precleared  with  MAb S1  (lanes 1-3) and then 
exposed to Genox 3.53 (lane 4) and 16.23 (lane 5). In lanes 6-10, the lysate was precleared 
with Genox 3.53 (lanes 6-8) and then exposed to S1 (lane 9) and 16.23 (lane 10). (c) Sequential 
immunoprecipitation  with MAb SI and R1. The lysate was precleared with MAb R1 (lanes 1- 
3) and then exposed to SI (lane 4) and 16.23 (lane 5). In lanes 6-10, the lysate was precleared 
with MAb SI (lanes 6-8) and then exposed to R1 (lane 9) and 16.23 (lane 10). 
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molecules could be identified.  MAb S1  and R1  appear to recognize the same 
molecules in  DQwl-bearing individuals since preclearing with R1  removed all 
molecules reacting with S1  and vice versa. In contrast, preclearing with R1  or 
S 1 did not remove the molecules binding the Genox 3.53 antibody. Conversely, 
preclearing with Genox 3.53 did not remove molecules reacting with R1 or S1. 
Identical results were obtained  from four individuals bearing three different 
DQw 1-associated DR allospecificities. Therefore, it appears that DQw 1-bearing 
individuals  express two  similar but  distinct alioantigenic specificities that  are 
located on different molecules. The specificity defined by the MAb Genox 3.53 
(called  here  DQwA.1)  has  the  population  distribution  of the  classic  DQwl 
alloantigen (i.e., it is expressed in individuals bearing the DR antigens 1, 2, and 
w6).  The other specificity, which we have called  DQwB.1,  is  defined by the 
antibodies R 1 and S 1 and has a broader distribution than the DQwA. 1, showing 
an association also  with  DR4  and  DRw8  specificities.  The  MAb B3T/4,  also 
reported to be directed against the DQwl antigen (23), shows the same binding 
pattern as R1  and S1  (21, 24) and is therefore likely to be directed against the 
DQwB.1  specificity.  The  DQwA.1  and  DQwB.1  specificities are  located  on 
distinct  DQ-like molecules that  are encoded by  the same chromosome.  This 
strongly suggests that they are the products of distinct genes (DQA, DQB). The 
demonstration  of R1-Ge  +  as  well  as  RI÷Ge  -  molecules at  the  cell  surface, 
together with the population analysis showing that the R1  and Ge epitopes are 
HLA-iinked polymorphic determinants with  distinct  DR  antigen  associations, 
make it unlikely that the antibodies recognize different modifications of the same 
gene product. Two genes for DQ-iike alpha, as well as DQ-like beta chains have 
been identified in  the haploid genome (6,  7) and two distinct alpha and beta 
chains have been detected in some homozygous cells (8, 9). In addition, an I-A- 
like molecule defined by MAb 33.1 has been isolated from several different LCL 
including DQwl-bearing cells. By amino acid sequence analysis these molecules 
are distinct from DQwl molecules defined by Genox 3.53 (10). It is possible that 
the DQwB. 1 ailospecificity defined by MAb R1 and S1 (and presumably B3T/4) 
is located on these I-A-like molecules. 
In  man as  well as  in  the  mouse,  structural  polymorphism of the  I-E  (DR) 
molecules resides almost  entirely in  the  beta  subunit,  while  in  the  I-A (DQ) 
molecules, both subunits are extensively polymorphic (13, 25, 26). For the DQ 
antigens this has been shown by two-dimensional gel electrophoretic analysis of 
antigens precipitated from homozygous LCL (3,  13, 27) as well as by restriction 
endonuclease analysis using DQ-specific probes (28). However, it has been noted 
(6) that the polymorphism observed by restriction endonuclease analysis is limited 
to one of the two identified alpha and beta chain genes, while the other two 
appear, thus far, to be invariant.  Since the subunit locations of the R1  and Ge 
epitopes are not yet known, the following models are consistent with the presence 
of Ge+R1 -  and Ge-R1 ÷ molecules in heterozygous cells.  Both  epitopes could 
reside on alpha or beta chains or one epitope may reside on an alpha chain and 
the other on a beta chain. Preliminary Western blotting analyses on immunopre- 
cipitates indicate that Ge+R 1  + and Ge+S 1  + molecules exist, which would suggest 
that the latter alternative may be correct. If this is indeed the case, the observa- 
tions reported here of independent immunoprecipitates indicate that alpha-beta JOHNSON  AND WANK  1357 
complementation (trans and/or cis) is a regular occurrence in EBV-transformed 
B lymphocytes. Studies are in progress to directly determine the location of the 
R 1, S 1, and Ge epitopes and to analyze their interactions in homozgous as well 
as heterozygous cells. 
Summary 
The  monoclonal  antibodies  Genox  3.53,  SI,  and  R1  define  polymorphic 
epitopes localized to DQ molecules. All three antibodies showed a strong associ- 
ation  with  the  HLA-DR antigens  1,  2,  and  w6 when  tested on a  panel  of 68 
unrelated individuals,  suggesting that they all recognized the DQwl  allospecif- 
icity. However, segregation analysis and binding studies with a panel of HLA-D/ 
DR homozygous cells indicated  that  these  monoclonal  antibodies defined two 
different  alloantigens.  Cells  homozygous  for  DR  1,  2,  or  w6  expressed  the 
epitopes defined by all three antibodies (i.e., S1, R1, and Ge) while cells homo- 
zygous for DR4 and  DRw8 expressed only the S1  and R1  epitopes. Sequential 
immunoprecipitation  analyses in  S I+/RI+/Ge+  individuals,  in  which  the  three 
epitopes were shown by segregation analysis to be encoded by the  same chro- 
mosome, revealed two distinct DQ-like molecules. While R 1 and S 1 appeared to 
reside  on  the  same  molecule,  the  epitope  defined  by Genox  3.53  was  on  a 
different molecule. Identical results were obtained with DRI-, DR2-, or DRw6- 
bearing  cells.  Thus  it appears  that  DQwl-bearing  individuals  express two cis- 
encoded DQ-like molecules that carry distinct alloantigenic specificities. 
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